methyl 3-bromo-8-methyl-imidazo[1,2-a]pyridine-6-carboxylate, ≥98.99%
CAS No.：
Cat. No.: SC261737
In Stock
Price on Request
Contact us for pricing, MOQ, and lead time
Product Name :methyl 3-bromo-8-methyl-imidazo[1,2-a]pyridine-6-carboxylate
Cat. No.: :SC261737
Purity / Specification :≥98.99%
CAS No. :1427324-37-5
MDL No. :—
Molecular Formula :C10H9BrN2O2
LogP :2.19
Molecular Weight :269.10
TPSA :43.6
Category :Drug Discovery
HSN Code :—
SMILES Code :COC(=O)c1cc(C)c2ncc(Br)n2c1
Melting Point :—
InChI Key : :SFLKTGHXDDGMHK-UHFFFAOYSA-N
Boiling Point :No data available
Application Note
AI GeneratedGenerated by AI. Verify before use in regulatory documents.
Lipinski & ADMET Properties
Computational estimateLipinski Rule of 5
iMW ≤ 500 Da✓ 269.1 Da
LogP ≤ 5✓ 2.19
HBD ≤ 5✓ 0
HBA ≤ 10✓ 3
Max 1 violation allowed for oral bioavailability.
Drug-likeness Score
i91/100
Excellent drug-like profile
Predicted LogP
i2.19log units
Optimal range (0–3)
CNS Permeability
iClark model · J Pharm Sci, 1999
CNS+ likely
TPSA 43.6Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−
Requires experimental confirmation.
⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.